Analyst Recommendations
1.80 -0.11(-5.76%)09/16/2024
Esperion Therapeutics Inc. (ESPR)
Esperion Therapeutics Inc. (ESPR)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 13 |
Underperform | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades